RCM
TMO icon

Raleigh Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Raleigh Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Sell
73
-14
-16% -$6.72K 0.01% 300
2026
Q1 		$43K Buy
87
+13
+18% +$7.05K 0.01% 290
2025
Q4 		$43.1K Sell
74
-3
-4% -$1.7K 0.02% 298
2025
Q3 		$37.5K Sell
77
-7
-8% -$3.26K 0.01% 282
2025
Q2 		$34.2K Sell
84
-5
-6% -$2.09K 0.01% 292
2025
Q1 		$44.4K Sell
89
-109
-55% -$59K 0.02% 280
2024
Q4 		$103K Sell
198
-6
-3% -$3.3K 0.04% 245
2024
Q3 		$126K Sell
204
-5
-2% -$2.96K 0.05% 237
2024
Q2 		$116K Buy
209
+31
+17% +$17.8K 0.05% 237
2024
Q1 		$104K Buy
178
+74
+71% +$41.5K 0.04% 239
2023
Q4 		$55K Buy
104
+22
+27% +$10.6K 0.03% 276
2023
Q3 		$41.3K Buy
82
+27
+49% +$14.4K 0.02% 281
2023
Q2 		$28.7K Sell
55
-24
-30% -$13K 0.01% 321
2023
Q1 		$45.6K Buy
79
+55
+229% +$31K 0.02% 258
2022
Q4 		$13.2K Buy
24
+7
+41% +$3.71K 0.01% 382
2022
Q3 		$9K Buy
17
+6
+55% +$3.36K 0.01% 390
2022
Q2 		$6K Hold
11
– – ﹤0.01% 428
2022
Q1 		$7K Buy
+11
New +$6.32K ﹤0.01% 424

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Raleigh Capital Management's TMO Position: Q2 2026 in Review

Raleigh Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, selling an estimated $6.72K and leaving 73 shares worth $36.8K. The position accounts for 0.01% of the portfolio, ranked #300.

Raleigh Capital Management first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $126K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Raleigh Capital Management held 73 shares of Thermo Fisher Scientific worth $36.8K as of Q2 2026.
  • Raleigh Capital Management sold 14 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.72K.
  • Thermo Fisher Scientific made up 0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #300 holding.
  • Raleigh Capital Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • Raleigh Capital Management's Thermo Fisher Scientific position peaked at $126K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.